A61L 2300/236
Glycosaminoglycans
Official title: Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
A61L2300/236 (Glycosaminoglycans) appears on 260 US grants and 360 published applications in this corpus.
Search patents in A61L- Granted patents
- 260
- Published applications
- 360
- Assignees
- 224
- Inventors
- 730
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 5 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 9 | 0 |
| 1999 | 5 | 0 |
| 2000 | 8 | 0 |
| 2001 | 14 | 4 |
| 2002 | 7 | 13 |
| 2003 | 4 | 7 |
| 2004 | 3 | 7 |
| 2005 | 3 | 6 |
| 2006 | 2 | 7 |
| 2007 | 1 | 15 |
| 2008 | 5 | 13 |
| 2009 | 2 | 14 |
| 2010 | 7 | 8 |
| 2011 | 6 | 13 |
| 2012 | 6 | 7 |
| 2013 | 8 | 6 |
| 2014 | 9 | 13 |
| 2015 | 8 | 20 |
| 2016 | 14 | 23 |
| 2017 | 14 | 17 |
| 2018 | 14 | 22 |
| 2019 | 9 | 20 |
| 2020 | 8 | 24 |
| 2021 | 9 | 27 |
| 2022 | 10 | 18 |
| 2023 | 13 | 14 |
| 2024 | 15 | 20 |
| 2025 | 16 | 12 |
| 2026 | 5 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Reinforced biocompatible scaffold4 Aug 2026US 12,697,416 B2Global Surgical Innovations Pty Ltd
- Composite ultrathin coating film with inhibitory activity against hyperinflammatory response and bacteria, implant including same, and preparation method therefor5 May 2026US 12,616,778 B2The Industry & Academic Cooperation in Chungnam National University (IAC)
- Valve material with combined anti-clotting and anti-calcification properties and preparation method31 Mar 2026US 12,589,187 B2Jilin Venus Haoyue Medical Limited
- System and methods for delivering a dermal filler10 Mar 2026US 12,569,589 B2Allure Medical Spa PLLC
- Delivery systems for administration of cationic biological actives17 Feb 2026US 12,551,596 B2Allvivo Vascular, Inc.
- Sodium alginate and hyaluronic acid blended hydrogel matrix17 Sep 2026US 2026/0273140 A1Alafair Biosciences, Inc.
- Biomaterial comprising at least one elastomeric matrix and a non-sulfated polysaccharide and uses thereof6 Aug 2026US 2026/0224780 A1Centre National De La Recherche Scientifique
- Disulfide crosslinked hyaluronic acid gel for postoperative abdominal (pelvic) adhesion prevention and preparation method thereof6 Aug 2026US 2026/0224784 A1Bioregen Biomedical (Changzhou) Co., Ltd.
- Biocompatible powder-type hemostatic agent and method for producing same11 Jun 2026US 2026/0158188 A1Theracion Biomedical Co., Ltd.
- Cell free vascular grafts and graft materials for cellular recruitment9 Apr 2026US 2026/0097149 A1The Research Foundation for The State University of New York
Most cited
By later US patents
- Drug release stent coating process951US 5,837,313 ASchneider (USA) Inc. · 1998
- Medical devices with long term non-thrombogenic coatings824US 6,120,536 ASchneider (USA) Inc. · 2000
- Drug coating with topcoat787US 6,099,562 ASchneider (USA) Inc. · 2000
- Endoprosthetic device with therapeutic compound544US 5,674,242 AQuanam Medical Corporation · 1997
- Medical device polymer536US 5,447,724 AHarbor Medical Devices, Inc. · 1995